San Diego State University is responsible for ensuring that recombinant DNA research or experiments involving biological materials
or potentially hazardous materials are conducted in compliance with the
NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines)
CDC Biosafety in Microbiological and Biomedical Laboratories
guidelines to promote safe and responsible practices. On behalf of SDSU, the Institutional Biosafety Committee (IBC)
reviews research for this purpose. The IBC is a committee of the University Research Council appointed by the Vice
President for Research. Graduate and Research Affairs' Division of Research Affairs provides administrative support
to the IBC. The IBC membership is determined based on federal guidance and includes a biosafety officer, an animal
expert, scientists, and private citizens.
Principal Investigators using biohazardous materials or conducting
experiments involving recombinant DNA in their laboratories must obtain approval from the IBC. To initiate this process,
the investigator must complete a
Biological Use Authorization (BUA)
Form. The BUA may be reviewed and approved by the Institutional Biosafety Officer (IBO) for BSL-1 experiments.
The IBO and the IBC will review research involving BSL-2 or BSL-3 experiments.
Note: Documents in Microsoft Word Format (Doc or Docx) require Microsoft Word Viewer to view; download Microsoft Word Viewer.
NEW BUA Annual Continuation Forms
Beginning on January 1, 2016, PIs holding a current BUA will be required to submit an annual continuation form. This form can be found on the Biosafety Program website.
For information specific to the Institutional Biosafety Committee, contact Graduate and Research Affairs'
Division of Research Affairs at 619-594-0905 or firstname.lastname@example.org.
For information regarding SDSU's
Biosafety Program please visit
SDSU Department of Environmental Health and Safety.
For Institutional policies see the SDSU Biosafety Manual or contact:
Sheryl MajorBiosafety Officer Email: email@example.comPhone: (619) 594-6965